Maintained Improvement With Baricitinib in Adult PatientsWith Moderate-to-Severe Atopic Dermatitis Who Were Treated for up to 104Weeks in a Randomised Tral: Physician Assessments
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要